Lyn is an important component of the signal transduction pathway specific to FLT3/ITD and can be a therapeutic target in the treatment of AML with FLT3/ITD. (Q40182148)
Jump to navigation
Jump to search
scientific article published on 18 January 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lyn is an important component of the signal transduction pathway specific to FLT3/ITD and can be a therapeutic target in the treatment of AML with FLT3/ITD. |
scientific article published on 18 January 2007 |
Statements
1 reference
Lyn is an important component of the signal transduction pathway specific to FLT3/ITD and can be a therapeutic target in the treatment of AML with FLT3/ITD. (English)
1 reference
Okamoto M
1 reference
Hayakawa F
1 reference
Miyata Y
1 reference
Watamoto K
1 reference
Emi N
1 reference
Abe A
1 reference
Kiyoi H
1 reference
Towatari M
1 reference
Naoe T
1 reference
18 January 2007
1 reference
1 reference
Identifiers
1 reference